The treatment of murine hepatoma (Hepa-1c1c7) cells with swietenine also induces NAD(P)H quinone oxidoreductase 1 (NQO1) dose-dependently, supporting the activation of NRF2 observed in RAW264.7 cells [61]. The gene discussed is NQO1; the disease is hepatocellular carcinoma.